The journey to IPO

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

It’s just over 12 months since we invited a small number of local companies to learn how becoming a publicly listed company could offer Northern Ireland businesses a great opportunity for growth, for profit – and even for a managed exit.

 

At that time, Northern Ireland - once boasting six active, publicly listed companies – had just two. But now we’ve got a new plc in Fusion Antibodies plc.

A week before Christmas, Belfast-based contract research organisation Fusion Antibodies plc, successfully floated on AIM with a market capitalisation of £18.1m. Fusion raised £5.5m from the market and with the subscription oversubscribed, and its shares climbed 35% on its first day of trading (18 December 2017) before closing at 123.5 pence.

As auditors and reporting accountants, PwC worked closely with Fusion to advise and help prepare the Queen's University spin-out for their IPO. Fusion’s success reminds us that smaller companies can go to the City and play with the big boys and that businesses in Northern Ireland should not be afraid of going for an IPO.

Paul Kerr (CEO) and James Fair (CFO) share their experience of flotation.

loading-player

Playback of this video is not currently available

Contact us

General Enquiries
Northern Ireland, PwC United Kingdom
Tel: +44 (0)289 024 5454
Email

Student Recruitment
Northern Ireland, PwC United Kingdom
Tel: +44 (0)289 041 5393
Email

Experienced Careers
Northern Ireland, PwC United Kingdom
Tel: +44 (0)289 024 5454
Email

Follow us: